Any adderall / vyvanse users here?
    3/12/2026

    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    RU58841 →

    a potent but unapproved and potentially problematic topical anti-androgen

    At a glance
    In this question or advice post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Adderall and Vyvanse may contribute to hair loss by stressing the dopamine system and increasing cortisol levels. Users discuss potential treatments like Minoxidil, finasteride, and RU58841 for managing hair loss.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community I can’t continue using oral minoxidil. I want to so badly though!

       30 upvotes 1 year ago
      The user experienced anxiety and heart pounding from oral minoxidil, despite its effectiveness, and switched back to topical minoxidil. After managing anxiety, they found oral minoxidil more effective, but side effects differ for each person.

      community Epidemic of brand names working wildly different, if at all.

       5 upvotes 7 years ago
      The conversation discusses the variability in effectiveness of medications, including finasteride, and questions whether different manufacturers impact results. The user suggests sharing successful brands to help others identify effective options.

      community 1 Year on Finasteride, Help. (23, M)

       4 upvotes 1 week ago
      A 23-year-old male has been using Finasteride for a year and added Minoxidil in January 2026 but hasn't seen significant improvement in hair loss. Users suggest considering Dutasteride and oral Minoxidil for better results and emphasize consistency with Minoxidil application.

    Related Research

    4 / 4 results
      What's New: Newly Approved Drugs for Children

      research What's New: Newly Approved Drugs for Children

      July 2003 in “Pediatrics in review”
      This article reviews 12 newly approved drugs with pediatric indications from 2001, discussing their clinical importance for general pediatricians, but reports no new clinical results.
      Update on Psychodermatological Disorders

      research Update on psychodermatological disorders

      5 citations , February 2010 in “Expert Review of Dermatology”
      This article reviews the interconnectedness of the skin and nervous system and discusses various treatment options for psychophysiological skin disorders, reporting no new clinical results.